萬洲(00288.HK):萬隆已辭任行政總裁 郭麗軍接任
萬洲(00288.HK)公布,萬隆已辭任行政總裁,自8月12日(今日)起生效,但將留任執行董事、董事會主席、提名委員會主席、食品安全委員會主席及風險管理委員會主席。而執行董事郭麗軍已獲委任為行政總裁,繼任萬隆職務。
董事會同時宣布,萬隆的兒子萬宏偉已獲委任為執行董事兼董事會副主席、公司環境、社會及管治委員會以及食品安全委員會的成員,今日起生效。
另外,郭麗軍已辭任首席財務官,而甄錦燕則已獲委任為首席財務官,並獲委任為公司副總裁,負責財務管理。而周峰獲委任為公司副總裁,負責國際貿易,以及王登峰獲委任為副總裁,負責營運管理,均自今日起生效。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.